BlackRock’s Belite Bio BLTE Stock Holding History

BlackRock’s Portfolio BLTE Stock Details BLTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,805	Closed	-$82.6K	–	5287
2023 Q4	$82.6K	Buy	+1,805	New	+$69.4K	﹤0.01%	4862
2023 Q3	–	Sell	-966	Closed	-$13.8K	–	5454
2023 Q2	$13.8K	Sell	966 -91	-9%	-$2.07K	﹤0.01%	5233
2023 Q1	$31.6K	Buy	1,057 +186	+21%	+$5.65K	﹤0.01%	5188
2022 Q4	$26.3K	Buy	+871	New	+$25.7K	﹤0.01%	5344

Other funds holding BLTE

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

VEA

Virtus ETF Advisers New York $215M AUM 53.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

BlackRock's BLTE Position: Q1 2024 in Review

BlackRock sold out of Belite Bio (BLTE) in Q1 2024, closing a stake of 1,805 shares — an estimated $82.6K sold.

BlackRock first reported a position in BLTE in Q4 2022 and held it in 4 quarters. The position peaked at $82.6K in Q4 2023. 11 funds tracked by Wall St. Rank hold BLTE as of Q1 2024.

BlackRock reported no remaining Belite Bio position as of Q1 2024 after selling out during the quarter.
BlackRock sold 1,805 Belite Bio shares in Q1 2024, an estimated $82.6K.
BlackRock first reported a position in Belite Bio in Q4 2022 and held it in 4 quarters.
BlackRock's Belite Bio position peaked at $82.6K in Q4 2023.
11 funds tracked by Wall St. Rank held Belite Bio as of Q1 2024.

Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.